Prestige Consumer Healthcare (PBH) Goodwill & Intangibles (2010 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Goodwill & Intangibles of $2.9 billion in Q4 2025, up 2.25% quarter-over-quarter from $2.8 billion in Q3 2025, and up 1.58% on a YoY basis from $2.8 billion in Q4 2024.
Prestige Consumer Healthcare (PBH) Goodwill & Intangibles (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Goodwill & Intangibles history runs 16 years deep, the most recent figure standing at $2.9 billion for Q4 2025.
- In Q4 2025, Goodwill & Intangibles rose 1.58% year-over-year to $2.9 billion; the TTM figure through Dec 2025 stood at $2.9 billion (up 1.58% YoY), while the FY2025 annual figure was $2.8 billion, down 0.9% from the prior year.
- Goodwill & Intangibles was $2.9 billion for Q4 2025 at Prestige Consumer Healthcare, up from $2.8 billion in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $3.3 billion in Q4 2021 to a low of $2.8 billion in Q3 2025.
- Historically, Goodwill & Intangibles has averaged $3.0 billion across 5 years, with a median of $2.9 billion in 2023.
- The sharpest annual moves came in 2022 and 2023: Goodwill & Intangibles climbed 7.26% in 2022, then decreased 12.4% in 2023.
- A 5-year view of Goodwill & Intangibles shows it stood at $3.3 billion in 2021, then fell by 1.09% to $3.2 billion in 2022, then decreased by 12.03% to $2.9 billion in 2023, then retreated by 0.65% to $2.8 billion in 2024, then advanced by 1.58% to $2.9 billion in 2025.
- The last three Goodwill & Intangibles figures came in at $2.9 billion (Q4 2025), $2.8 billion (Q3 2025), and $2.8 billion (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.88 Bn |
| Sep 30, 2025 | 2.82 Bn |
| Jun 30, 2025 | 2.82 Bn |
| Mar 31, 2025 | 2.82 Bn |
| Dec 31, 2024 | 2.84 Bn |
| Sep 30, 2024 | 2.85 Bn |
| Jun 30, 2024 | 2.85 Bn |
| Mar 31, 2024 | 2.85 Bn |
| Dec 31, 2023 | 2.86 Bn |
| Sep 30, 2023 | 2.86 Bn |
| Jun 30, 2023 | 2.86 Bn |
| Mar 31, 2023 | 2.87 Bn |
| Dec 31, 2022 | 3.25 Bn |
| Sep 30, 2022 | 3.25 Bn |
| Jun 30, 2022 | 3.26 Bn |
| Mar 31, 2022 | 3.28 Bn |
| Dec 31, 2021 | 3.28 Bn |
| Sep 30, 2021 | 3.27 Bn |
| Jun 30, 2021 | 3.05 Bn |
| Mar 31, 2021 | 3.05 Bn |